Please login to the form below
RMS
This page shows the latest RMS news and features for those working in and with pharma, biotech and healthcare.
BMS shares positive long-term data for Zeposia in relapsing multiple sclerosis
Bristol Myers Squibb (BMS) has shared new long-term data from a study evaluating Zeposia (ozanimod) in patients with relapsing forms of multiple sclerosis (RMS). ... 76% of RMS patients treated with Zeposia were free of six-month confirmed disability
Latest news
-
Roche reports positive results for drug for relapsing forms of MS
Fenebrutinib has yet to be hit by any FDA restrictions, and the phase 3 clinical trial programme assessing the drug in RMS and primary progressive MS is ongoing.
-
AI model shows promise in detecting lung cancer earlier
The Royal Marsden Cancer Charity, the National Institute for Health and Care Research, RM Partners and Cancer Research UK also supported the study.
-
ICR research shows blood tests could help guide the treatment for children’s cancer
RMS is a rare type of cancer that forms in soft tissue, specifically skeletal muscle tissue or sometimes hollow organs such as the bladder or uterus. ... Liquid biopsies have the potential to transform how we monitor and treat children with RMS.
-
Roche shares new positive Ocrevus data for MS patients
Relapsing forms of MS (RMS) include people with RRMS and people with SPMS who continue to experience relapses.
-
Novartis’ Kesimpta trial evaluates treatment of COVID-19 in MS patients
For those patients diagnosed with relapsing forms of MS (RMS) – including RRMS and secondary progressive MS (SPMS) with active disease – episodic attacks of symptoms are common and are known as relapses.
More from news
Approximately 0 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
Social media and inflation penalties for generic drugs
Tomorrow. Most pharmaceutical manufacturers employ a Revenue Management System (RMS) designed to operate under specific parameters, given the current governmental landscape.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Matt de Gruchy to lead PR agency Reynolds Mackenzie
The RM brand has long been associated with media relations excellence, and is recognised for this by a leading book of clients.
-
Huntingdon Life Sciences appoints Joseph Bedford
The job spans the company's contract research services (CRS) and research models services (RMS) business units, with responsibility for global marketing, business intelligence, strategic planning and some aspects of corporate ... Joe's strong expertise
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Food Allergy – Is avoidance the only option?
Accessed May 11, 2022. Quach LL, John RM. Psychosocial Impact of Growing Up With Food Allergies.
-
We are looking for new talent! - Quant RM role
Branding Science are looking for a Quantitative Research Manager to join the EU team. The role requires a passion for quantitative research. You will be working alongside an experienced Director. This is an exciting opportunity for someone who is
-
We are looking for new talent! - Qual RM
We are looking for a Research Manager to join our EU team who will be responsible for managing healthcare/pharmaceutical projects. You will need to have a commitment to producing high quality work and have a strong desire to meet and exceed goals.
-
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
When I was diagnosed with relapsing multiple sclerosis (RMS) in 2008, the landscape for disease-modifying therapies (DMTs) looked very different from now. ... There were five DMTs available on the NHS for RMS and nothing for people with progressive MS.
-
RMS Research & Marketing Services
RMS can offer you a full range of direct marketing services to help you in your promotion. ... From mailing assembly and despatch right through to offer fulfilment RMS will give you services tailored to you exact requirements.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
